PMA device
Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)
Insightec · Mr-Guided Focused Ultrasound System (POH, Class III) · First FDA decision Apr 14, 2020, newest Dec 8, 2022Essential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
43
Naming "Exablate 4000"
MAUDE reports
235
Brand "Exablate 4000", since 2015
PubMed studies
15
Mentioning "Exablate 4000"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)PMA supplement
P150038-S022 · Decided Dec 8, 2022 · 177 days after receipt · Normal 180 Day Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
- ExAblate 4000 System (Exablate Neuro or the system)PMA supplement
P150038-S012 · Decided Apr 14, 2020 · 250 days after receipt · Normal 180 Day Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's DiseaseLocal determinationIn effectL37729Noridian Healthcare Solutions, LLCUpdated Sep 2, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Exablate 4000", any status and sponsor, newest update first.
Sunnybrook Health Sciences CentreAcademic, hospital or other
NCT07113665 · 10 participants (planned) · Start Sep 5, 2025 · Primary completion Aug 2028
Device: ExAblate Neuro 4000 · For: Anorexia Nervosa (DSM-IV Revised Criteria)
Sites: Toronto, Canada
Children's National Research InstituteAcademic, hospital or other
NCT07796061 · 45 participants (planned) · Start Dec 2026 · Primary completion Dec 2031
Device: BBB Disruption · For: DMG; DIPG
Sites: Washington D.C., District of Columbia
Taipei Veterans General Hospital, TaiwanGovernment (non-federal)
NCT06292494 · 10 participants (planned) · Start Jan 1, 2024 · Primary completion Dec 31, 2027
Device: Exablate 4000 Transcranial MRgfUS System · For: Focused Ultrasound; MR-guided FUS; Drug Refractory Epilepsy and 2 more
Sites: Taipei, Taiwan
40 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Exablate 4000", and for the whole product code for context.
This brand
235 reports: 0 malfunction, 231 injury, 4 death
Whole product code POH
262 reports: 2 malfunction, 254 injury, 5 death
Newest reports for this brand
- Exablate 4000Injury
9615058-2026-00025 · Received Oct 21, 2026 · Event dated Jun 25, 2026
Device type: Mr-Guided Focused Ultrasound System (POH)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Fatigue; Balance Problems; Decreased Appetite
- Exablate 4000Injury
9615058-2026-00024 · Received Aug 24, 2026 · Event dated Aug 4, 2026
Device type: Mr-Guided Focused Ultrasound System (POH)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Intracranial Hemorrhage
- Exablate 4000Injury
9615058-2026-00021 · Received Jul 15, 2026 · Event dated Jan 1, 2022
Device type: Mr-Guided Focused Ultrasound System (POH)
Device problem as coded: Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
Patient problem as coded: Intracranial Hemorrhage
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Exablate 4000"[tiab]. The summary above synthesizes these.
- Transcranial focused ultrasound phase correction using the hybrid angular spectrum method.
Leung SA, Moore D, Webb TD, et al. · Sci Rep · 2021Research Support, N.I.H., Extramural
- Comparison between MR and CT imaging used to correct for skull-induced phase aberrations during transcranial focused ultrasound.
Leung SA, Moore D, Gilbo Y, et al. · Sci Rep · 2022Research Support, N.I.H., Extramural
- Sonoablation and application of MRI guided focused ultrasound in a preclinical model.
Zibly Z, Graves CA, Harnof S, et al. · J Clin Neurosci · 2014
- Cavitation-based third ventriculostomy using MRI-guided focused ultrasound.
Alkins R, Huang Y, Pajek D, et al. · J Neurosurg · 2013Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Predicting lesion size by accumulated thermal dose in MR-guided focused ultrasound for essential tremor.
Huang Y, Lipsman N, Schwartz ML, et al. · Med Phys · 2018
- Intracranial Sonodynamic Therapy With 5-Aminolevulinic Acid and Sodium Fluorescein: Safety Study in a Porcine Model.
Raspagliesi L, D'Ammando A, Gionso M, et al. · Front Oncol · 2021
- [Quality Control Test of Transcranial MRI-guided Focused Ultrasound Treatment System before Surgery].
Bian X, Qin Q, Zhang X, et al. · Zhongguo Yi Liao Qi Xie Za Zhi · 2021
- Ultrasound focusing using magnetic resonance acoustic radiation force imaging: application to ultrasound transcranial therapy.
Hertzberg Y, Volovick A, Zur Y, et al. · Med Phys · 2010
- A dual-mode hemispherical sparse array for 3D passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device.
Crake C, Brinker ST, Coviello CM, et al. · Phys Med Biol · 2018Research Support, N.I.H., Extramural
- Optimal imaging of in vitro clot sonothrombolysis by MR-guided focused ultrasound.
Durst C, Monteith S, Sheehan J, et al. · J Neuroimaging · 2013Research Support, Non-U.S. Gov't
- The efficacy and limits of magnetic resonance-guided focused ultrasound pallidotomy for Parkinson's disease: a Phase I clinical trial.
Jung NY, Park CK, Kim M, et al. · J Neurosurg · 2019
- Effects of varying duty cycle and pulse width on high-intensity focused ultrasound (HIFU)-induced transcranial thrombolysis.
Hölscher T, Raman R, Fisher DJ, et al. · J Ther Ultrasound · 2013
Other devices of this type
Also filed under product code POH.
- Exablate Model 4000 SystemInsightec · PMA 2026
- ExAblate Neuro ThalamotomyInsightec · PMA 2017
- Exablate NeuroInsightec · PMA 2024
- Exablate 4000 (Neuro) Type 1.0 & 1.1Insightec · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.